Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × gemcitabine-oxaliplatin regimen × Clear all

NCT06320301 2024-03-20

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT01267344 2016-05-04

BTC

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma